Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

THBS2

Introduction

Thrombospondin 2, also known as THBS2, is a human gene.[1]

The protein encoded by this gene belongs to the thrombospondin family. It is a disulfide-linked homotrimeric glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. This protein has been shown to function as a potent inhibitor of tumor growth and angiogenesis. Studies of the mouse counterpart suggest that this protein may modulate the cell surface properties of mesenchymal cells and be involved in cell adhesion and migration.[1]

References

References

  1. ↑ 1.0 1.1 “Entrez Gene: THBS2 thrombospondin 2”.
Further reading

Further reading

  • Bornstein P, Kyriakides TR, Yang Z; et al. (2001). “Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis”. J. Investig. Dermatol. Symp. Proc. 5 (1): 61–6. doi:10.1046/j.1087-0024.2000.00005.x. PMID 11147677.
  • O’Rourke KM, Laherty CD, Dixit VM (1993). “Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers”. J. Biol. Chem. 267 (35): 24921–4. PMID 1459996.
  • LaBell TL, Milewicz DJ, Disteche CM, Byers PH (1992). “Thrombospondin II: partial cDNA sequence, chromosome location, and expression of a second member of the thrombospondin gene family in humans”. Genomics. 12 (3): 421–9. PMID 1559694.
  • LaBell TL, Byers PH (1993). “Sequence and characterization of the complete human thrombospondin 2 cDNA: potential regulatory role for the 3′ untranslated region”. Genomics. 17 (1): 225–9. doi:10.1006/geno.1993.1308. PMID 8406456.
  • Adolph KW, Liska DJ, Bornstein P (1997). “Analysis of the promoter and transcription start sites of the human thrombospondin 2 gene (THBS2)”. Gene. 193 (1): 5–11. PMID 9249061.
  • Kyriakides TR, Zhu YH, Smith LT; et al. (1998). “Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis”. J. Cell Biol. 140 (2): 419–30. PMID 9442117.
  • Adolph KW (1999). “Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues”. Biochem. Biophys. Res. Commun. 258 (3): 792–6. doi:10.1006/bbrc.1999.0710. PMID 10329465.
  • Carron JA, Bowler WB, Wagstaff SC, Gallagher JA (1999). “Expression of members of the thrombospondin family by human skeletal tissues and cultured cells”. Biochem. Biophys. Res. Commun. 263 (2): 389–91. doi:10.1006/bbrc.1999.1380. PMID 10491303.
  • Bein K, Simons M (2000). “Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity”. J. Biol. Chem. 275 (41): 32167–73. doi:10.1074/jbc.M003834200. PMID 10900205.
  • Hawighorst T, Velasco P, Streit M; et al. (2001). “Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism”. EMBO J. 20 (11): 2631–40. doi:10.1093/emboj/20.11.2631. PMID 11387198.
  • Misenheimer TM, Hahr AJ, Harms AC; et al. (2002). “Disulfide connectivity of recombinant C-terminal region of human thrombospondin 2”. J. Biol. Chem. 276 (49): 45882–7. doi:10.1074/jbc.M104218200. PMID 11590138.
  • Armstrong DJ, Hiscott P, Batterbury M, Kaye S (2002). “Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype”. Int. J. Biochem. Cell Biol. 34 (6): 588–93. PMID 11943589.
  • Li Z, Calzada MJ, Sipes JM; et al. (2002). “Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior”. J. Cell Biol. 157 (3): 509–19. doi:10.1083/jcb.200109098. PMID 11980922.
  • Armstrong LC, Björkblom B, Hankenson KD; et al. (2002). “Thrombospondin 2 inhibits microvascular endothelial cell proliferation by a caspase-independent mechanism”. Mol. Biol. Cell. 13 (6): 1893–905. doi:10.1091/mbc.E01-09-0066. Check |doi= value (help). PMID 12058057.
  • Hatakeyama H, Nishizawa M, Nakagawa A; et al. (2003). “Thrombospondin expression in aldosterone-producing adenomas”. Hypertens. Res. 25 (4): 523–7. PMID 12358136.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Boekholdt SM, Trip MD, Peters RJ; et al. (2002). “Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction”. Arterioscler. Thromb. Vasc. Biol. 22 (12): e24–7. PMID 12482844.
  • Kyriakides TR, Rojnuckarin P, Reidy MA; et al. (2003). “Megakaryocytes require thrombospondin-2 for normal platelet formation and function”. Blood. 101 (10): 3915–23. doi:10.1182/blood.V101.10.3915. PMID 12732502.
  • Kishi M, Nakamura M, Nishimine M; et al. (2003). “Loss of heterozygosity on chromosome 6q correlates with decreased thrombospondin-2 expression in human salivary gland carcinomas”. Cancer Sci. 94 (6): 530–5. PMID 12824879.

Template:WikiDoc Sources